Access Bio has ranked among the top searched stocks on 9 days within the past month.


As of 1:30 PM on the 16th, Access Bio is trading at 29,550 KRW, down 7.8% from the previous day. This represents a 29.61% increase compared to September 25. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past 5 days, individual investors have net purchased 468,452 shares, while foreign investors and institutions have net sold 530,387 shares and net purchased 3,045 shares, respectively.


On October 13, Access Bio became a market issue with the headline "Surge on US Approval of COVID-19 Diagnostic Kit."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing